GenetiSure Dx Postnatal Assay— 510(k) K163367
Substantially EquivalentAgilent Technologies, Inc.
FDA 510(k) clearance K163367 for GenetiSure Dx Postnatal Assay, Substantially Equivalent on 2017-08-11. Applicant: Agilent Technologies, Inc..
Clearance details
- Applicant
- Agilent Technologies, Inc.
- Product code
- Code PFX
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Santa Clara, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.